Article info

Download PDFPDF

Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease

Authors

  1. Correspondence to Dr Ambrogio Orlando, Division of Internal Medicine, “Villa Sofia-V. Cervello” Hospital, Palermo 90146, Italy; ambrogiorlando{at}gmail.com
View Full Text

Citation

Orlando A, Orlando R, Ciccia F, et al
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease

Publication history

  • Received December 21, 2016
  • Revised December 27, 2016
  • Accepted December 28, 2016
  • First published January 17, 2017.
Online issue publication 
August 10, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.